Then in the CHIP experiments by FOXO3 antibody, FOXO3 significantly occupied on the promoter of CTNNB1 in HCC and CRC wild type (WT) cells under the treatment of PS341 (Fig. 6f, top). The gene discussed is FOXO3; the disease is colorectal carcinoma.